組換えタンパク質の世界市場レポート 2024年

組換えタンパク質の市場規模は近年急速に拡大しています。2023年の21億2,000万米ドルから2024年には23億7,000万米ドルへと、CAGR11.6％で拡大します。この成長は、バイオ医薬品需要の増加、慢性疾患の増加、高齢化社会の進展、政府の取り組みと資金援助、研究・診断分野での応用拡大などに起因しています。

組換えタンパク質市場規模は、今後数年で急成長が見込まれます。2028年にはCAGR12.5％で37億9,000万米ドルに成長します。予測期間中に予想される成長機会は、個別化医療の採用拡大、バイオテクノロジー分野の急速な拡大、希少疾患への対応に向けた世界の取り組み、タンパク質工学技術の進歩、新興市場や未開拓機会の特定などに起因すると考えられます。予測期間に予想される世界の動向には、個別化医療の継続的拡大、バイオテクノロジー分野の急成長、治療用タンパク質に対する需要の高まり、新規治療ターゲットの出現、ワクチン開発への世界の注力などがあります。

規制当局による承認の増加が予想されることから、組換え蛋白質市場の今後の成長が期待されます。規制当局の承認は、ヒトを対象とする研究、特にがん、心血管疾患、内分泌疾患、ウイルス性疾患などの重篤な慢性疾患に対処する薬剤の研究にとって極めて重要です。2022年1月、医薬品評価研究センター（CDER）は、2021年に認可された50品目のうち38品目が米国で初めて認可されたと報告しました。これは前年からの顕著な増加であり、ファースト・イン・クラスの医薬品が2021年に承認された医薬品の54％を占めています。したがって、規制当局による承認件数の増加は、組換えタンパク質市場の成長を後押しする重要な要因となっています。

ヘルスケアの研究開発における政府の取り組みは、組み換えタンパク質市場の成長に貢献すると期待されています。様々な政府当局が、組換えタンパク質の調査を含むヘルスケアイニシアチブを支援するための具体的な行動やプログラムを実施しています。2022年、英国政府はヘルスケアの研究と製造を後押しするために2億6,000万ポンドの資金提供を発表し、NHS主導の健康研究、診断、治療開発を支援しています。ヘルスケアにおける研究開発のための政府のイニシアチブは、組換えタンパク質市場を前進させる上で重要な役割を果たしています。

北米は、2023年の組換えタンパク質市場で最大の地域でした。組換えタンパク質市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 組換えタンパク質市場の特徴

第3章 組換えタンパク質市場の動向と戦略

第4章 組換えタンパク質市場- マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界の組換えタンパク質市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 組換えタンパク質市場セグメンテーション

• 世界の組換えタンパク質市場、製品別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 抗体
• サイトカイン
• 免疫チェックポイントタンパク質
• ウイルス抗原
• 酵素
• 組換え調節タンパク質
• ホルモン
• その他の製品
• 世界の組換えタンパク質市場、用途別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 創薬開発
• 治療
• 調査
• その他の用途
• 世界の組換えタンパク質市場、エンドユーザー別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 製薬会社およびバイオテクノロジー会社
• 学術研究機関
• 診断研究所
• その他のエンドユーザー

第7章 組換えタンパク質市場の地域および国分析

• 世界の組換えタンパク質市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
• 世界の組換えタンパク質市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋の組換えタンパク質市場

第9章 中国の組換えタンパク質市場

第10章 インドの組換えタンパク質市場

第11章 日本の組換えタンパク質市場

第12章 オーストラリアの組換えタンパク質市場

第13章 インドネシアの組換えタンパク質市場

第14章 韓国の組換えタンパク質市場

第15章 西欧の組換えタンパク質市場

第16章 英国の組換えタンパク質市場

第17章 ドイツの組換えタンパク質市場

第18章 フランスの組換えタンパク質市場

第19章 イタリアの組換えタンパク質市場

第20章 スペインの組換えタンパク質市場

第21章 東欧の組換えタンパク質市場

第22章 ロシアの組換えタンパク質市場

第23章 北米の組換えタンパク質市場

第24章 米国の組換えタンパク質市場

第25章 カナダの組換えタンパク質市場

第26章 南米組換えタンパク質市場

第27章 ブラジルの組換えタンパク質市場

第28章 中東の組換えタンパク質市場

第29章 アフリカの組換えタンパク質市場

第30章 組換えタンパク質市場の競合情勢と企業プロファイル

• 組換えタンパク質市場の競合情勢
• 組換えタンパク質市場の企業プロファイル
  • Abcam plc
  • Abnova Corporation
  • Bio-Rad Laboratoroies Inc.
  • Merck Co. &KGaA
  • R&D Systems Inc.

第31章 世界の組換えタンパク質市場の競合ベンチマーキング

第32章 世界の組換えタンパク質市場競争力ダッシュボード

第33章 組換えタンパク質市場における主要な合併と買収

第34章 組換えタンパク質市場の将来展望と可能性分析

第35章 付録

“Recombinant Proteins Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on recombinant proteins market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for recombinant proteins? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The recombinant proteins market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Product: Antibodies; Cytokines; Immune Checkpoint Protein; Virus Antigens; Enzymes; Recombinant Regulatory Proteins; Hormones; Other Products
• 2) By Application: Drug And Discovery Development; Therapeutics; Research; Other Applications
• 3) By End User: Pharmaceutical And Biotechnology Companies; Academic And Research Institute; Diagnostic Laboratories; Other End Users
• Companies Mentioned: Abcam plc; Abnova Corporation; Bio-Rad Laboratoroies Inc.; Merck Co. & KGaA; R&D Systems Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Recombinant proteins are proteins that have been altered or edited using recombinant DNA technology. In this process, a plasmid is employed, containing the gene encoding the desired target protein, which is cloned downstream of a promoter region. These modified proteins find application in various fields, including pharmaceuticals, protein-based polymers for drug delivery, disease treatment through antibodies and enzymes, protein scaffolds for tissue engineering, and numerous other uses.

The primary types of recombinant protein products encompass antibodies, cytokines, immune checkpoint proteins, virus antigens, enzymes, recombinant regulatory proteins, hormones, and others. Antibodies, for example, are immune system components that circulate in the blood, identifying and neutralizing foreign objects such as bacteria and viruses. They are utilized across diverse applications, including drug and discovery development, therapeutics, research, and more. These recombinant proteins are predominantly utilized by pharmaceutical and biotechnology companies, academic and research institutes, diagnostic laboratories, and other relevant entities.

The recombinant proteins market research report is one of a series of new reports from The Business Research Company that provides recombinant proteins market statistics, including recombinant proteins industry global market size, regional shares, competitors with a recombinant proteins market share, detailed recombinant proteins market segments, market trends and opportunities, and any further data you may need to thrive in the recombinant proteins industry. The recombinant proteins market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The recombinant proteins market size has grown rapidly in recent years. It will grow from $2.12 billion in 2023 to $2.37 billion in 2024 at a compound annual growth rate (CAGR) of 11.6%. The growth observed in the historical period can be attributed to the increasing demand for biopharmaceuticals, the rising prevalence of chronic diseases, a growing aging population, government initiatives and funding, as well as the expanding applications in research and diagnostics.

The recombinant proteins market size is expected to see rapid growth in the next few years. It will grow to $3.79 billion in 2028 at a compound annual growth rate (CAGR) of 12.5%. The anticipated growth in the forecast period can be attributed to the increased adoption of personalized medicine, the rapid expansion of the biotechnology sector, global initiatives to address rare diseases, advancements in protein engineering techniques, and the identification of emerging markets and untapped opportunities. Key trends expected in the forecast period include the continued expansion of personalized medicine, rapid growth in the biotechnology sector, a heightened demand for therapeutic proteins, the emergence of novel therapeutic targets, and a global focus on vaccine development.

The anticipated increase in regulatory approvals is set to drive the growth of the recombinant protein market in the future. Regulatory approvals are crucial for research involving human subjects, particularly for drugs addressing severe chronic diseases such as cancer, cardiovascular diseases, endocrine diseases, and viral diseases. In January 2022, the Centre for Drug Evaluation and Research (CDER) reported that 38 out of 50 medications authorized in 2021 received their first U.S. approval. This represents a notable increase from the previous year, with first-in-class drugs comprising 54% of the drugs approved in 2021. Therefore, the growing number of regulatory approvals is a significant factor propelling the recombinant protein market's growth.

Government initiatives in healthcare research and development are expected to contribute to the growth of the recombinant protein market. Various government authorities are undertaking specific actions and programs to support healthcare initiatives, including research into recombinant proteins. In 2022, the UK government announced £260 million in funding to boost healthcare research and manufacturing, supporting NHS-led health research, diagnostics, and treatment development. Government initiatives for research and development in healthcare play a crucial role in driving the recombinant protein market forward.

Product innovation emerges as a prominent trend in the recombinant protein market, with major companies focusing on developing cutting-edge products to enhance their market positions. For instance, ProteoGenix introduced the XtenCHO Transient CHO Expression System in March 2022, aiming to improve biologics development. This system offers significant advantages, including higher yields, optimized plasmid stability, and streamlined protocols for enhanced efficiency in bioanalytical applications and drug development.

Collaborations and partnerships are strategic initiatives undertaken by major companies in the recombinant protein market to gain a competitive edge. In October 2023, ARTES Biotechnology GmbH collaborated with Basic Pharma to establish a streamlined supply chain process for developing and producing non-GMP recombinant proteins. This collaboration focuses on expediting the time-to-market for new pharmaceutical products, showcasing the potential benefits of partnerships in fostering innovation.

In December 2021, Thermo Fisher Scientific Inc. acquired PeproTech, Inc., enhancing its capabilities in serving high-growth cells and gene therapy. Thermo Fisher's acquisition allows them to integrate PeproTech's recombinant protein portfolio into their cell culture media products, providing clients with comprehensive offerings. PeproTech Inc., a recombinant protein producer based in the United States, specializes in developing and manufacturing recombinant cytokine products for life science research.

Major companies operating in the recombinant proteins market report are Abcam plc, Abnova Corporation, Bio-Rad Laboratoroies Inc., Merck Co. & KGaA, R&D Systems Inc., Proteintech Group Inc., RayBiotech Life Inc., GenScript Biotech Corporation, Elpiscience Biopharmaceuticals Co. Ltd., Elevian Inc., Gigagen Inc., Janssen- Cilag Pvt. Ltd., Sino Biological Inc., OriGene Technologies Inc., Feldan Therapeutics Inc., Randox Laboratories Ltd., Plant Biotechnology Inc., Infinite Enzymes Inc., Bio-Techne Corporation, Thermo Fisher Scientific Inc., PerkinElmer Inc., Crown Bioscience Inc., Airway Therapeutics Inc., Amgen Inc., Aviva Systems Biology Corp., Bracco Imaging S.p.A., Cardinal Health Inc., Eli Lilly and Company, Gamma Medica Inc., LambdaSpect Ltd

North America was the largest region in the recombinant protein market in 2023. The regions covered in the recombinant proteins market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the recombinant proteins market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The recombinant protein market consists of sales of recombinant monoclonal antibodies, interferons, and interleukins. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Recombinant Proteins Market Characteristics

3. Recombinant Proteins Market Trends And Strategies

4. Recombinant Proteins Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On the Market
• 4.2. Ukraine-Russia War Impact On the Market
• 4.3. COVID-19 Impact On the Market

5. Global Recombinant Proteins Market Size and Growth

• 5.1. Global Recombinant Proteins Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Recombinant Proteins Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Recombinant Proteins Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Recombinant Proteins Market Segmentation

• 6.1. Global Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Antibodies
• Cytokines
• Immune Checkpoint Protein
• Virus Antigens
• Enzymes
• Recombinant Regulatory Proteins
• Hormones
• Other Products
• 6.2. Global Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Drug And Discovery Development
• Therapeutics
• Research
• Other Applications
• 6.3. Global Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Pharmaceutical And Biotechnology Companies
• Academic And Research Institute
• Diagnostic Laboratories
• Other End Users

7. Recombinant Proteins Market Regional And Country Analysis

• 7.1. Global Recombinant Proteins Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Recombinant Proteins Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Recombinant Proteins Market

• 8.1. Asia-Pacific Recombinant Proteins Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Recombinant Proteins Market

• 9.1. China Recombinant Proteins Market Overview
• 9.2. China Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Recombinant Proteins Market

• 10.1. India Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Recombinant Proteins Market

• 11.1. Japan Recombinant Proteins Market Overview
• 11.2. Japan Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Recombinant Proteins Market

• 12.1. Australia Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Recombinant Proteins Market

• 13.1. Indonesia Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Recombinant Proteins Market

• 14.1. South Korea Recombinant Proteins Market Overview
• 14.2. South Korea Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Recombinant Proteins Market

• 15.1. Western Europe Recombinant Proteins Market Overview
• 15.2. Western Europe Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Recombinant Proteins Market

• 16.1. UK Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Recombinant Proteins Market

• 17.1. Germany Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Recombinant Proteins Market

• 18.1. France Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Recombinant Proteins Market

• 19.1. Italy Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Recombinant Proteins Market

• 20.1. Spain Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Recombinant Proteins Market

• 21.1. Eastern Europe Recombinant Proteins Market Overview
• 21.2. Eastern Europe Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Recombinant Proteins Market

• 22.1. Russia Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Recombinant Proteins Market

• 23.1. North America Recombinant Proteins Market Overview
• 23.2. North America Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Recombinant Proteins Market

• 24.1. USA Recombinant Proteins Market Overview
• 24.2. USA Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Recombinant Proteins Market

• 25.1. Canada Recombinant Proteins Market Overview
• 25.2. Canada Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Recombinant Proteins Market

• 26.1. South America Recombinant Proteins Market Overview
• 26.2. South America Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Recombinant Proteins Market

• 27.1. Brazil Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Recombinant Proteins Market

• 28.1. Middle East Recombinant Proteins Market Overview
• 28.2. Middle East Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Recombinant Proteins Market

• 29.1. Africa Recombinant Proteins Market Overview
• 29.2. Africa Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Recombinant Proteins Market Competitive Landscape And Company Profiles

• 30.1. Recombinant Proteins Market Competitive Landscape
• 30.2. Recombinant Proteins Market Company Profiles
  • 30.2.1. Abcam plc
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Abnova Corporation
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Bio-Rad Laboratoroies Inc.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Merck Co. & KGaA
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. R&D Systems Inc.
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Global Recombinant Proteins Market Competitive Benchmarking

32. Global Recombinant Proteins Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Recombinant Proteins Market

34. Recombinant Proteins Market Future Outlook and Potential Analysis

• 34.1 Recombinant Proteins Market In 2028 - Countries Offering Most New Opportunities
• 34.2 Recombinant Proteins Market In 2028 - Segments Offering Most New Opportunities
• 34.3 Recombinant Proteins Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

• 35.1. Abbreviations
• 35.2. Currencies
• 35.3. Historic And Forecast Inflation Rates
• 35.4. Research Inquiries
• 35.5. The Business Research Company
• 35.6. Copyright And Disclaimer